MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer

Conclusion: MYC up-regulation in the primary CRC tissues may be a potentially useful biomarker for selecting anti-EGFR combination therapy in neoadjuvant chemotherapy for CRC with liver metastasis.

Source: In Vivo - January 5, 2021 Category: Research Authors: KATO, T., MATSUHASHI, N., TOMITA, H., TAKAHASHI, T., IWATA, Y., FUKADA, M., YASUFUKU, I., SUETSUGU, T., IMAI, T., MORI, R., IMAI, H., TANAKA, Y., OKUMURA, N., HARA, A., YOSHIDA, K. Tags: Experimental Studies Source Type: research